Valentina Fodale
IRBM Science Park · 41 works · 2,288 citations · h-index 17
Top works
- Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome
- Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
- Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair
- Gerodermia osteodysplastica is caused by mutations in SCYL1BP1, a Rab-6 interacting golgin
- Mechanism of Cell Adaptation
- Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis
- Polyglutamine- and Temperature-Dependent Conformational Rigidity in Mutant Huntingtin Revealed by Immunoassays and Circular Dichroism Spectroscopy
- Loss of function of the E3 ubiquitin-protein ligase UBE3B causes Kaufman oculocerebrofacial syndrome
- Validation of Ultrasensitive Mutant Huntingtin Detection in Human Cerebrospinal Fluid by Single Molecule Counting Immunoassay
- Phosphoproteomic Analysis of Signaling Pathways in Head and Neck Squamous Cell Carcinoma Patient Samples
- Widespread and sustained target engagement in Huntington’s disease minipigs upon intrastriatal microRNA-based gene therapy
- Quantifying autophagy using novel LC3B and p62 TR-FRET assays
- Induction of Both CD8+ and CD4+ T-Cell–Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1
- Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors
- Polyglutamine expansion affects huntingtin conformation in multiple Huntington’s disease models
- SHOC2 subcellular shuttling requires the KEKE motif-rich region andN-terminal leucine-rich repeat domain and impacts on ERK signalling
- AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington’s disease mouse model
- Analysis of mutant and total huntingtin expression in Huntington’s disease murine models
- Quantifying Huntingtin Protein in Human Cerebrospinal Fluid Using a Novel Polyglutamine Length-Independent Assay
- Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease